Alymsys 100 mg/4 mL (25 mg/mL) vial Images
Generic Name: bevacizumab
This medication has been identified as Alymsys 100 mg/4 mL (25 mg/mL) vial and is used for Colorectal Cancer, Glioblastoma Multiforme, Fallopian Tube Cancer, Cervical Cancer, and Non Small Cell Lung Cancer. It belongs to the drug class VEGF/VEGFR inhibitors and is not a controlled substance.
Images of medication
Alymsys
- Generic Name
- bevacizumab
- Strength
- 100 mg/4 mL (25 mg/mL) vial
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 70121-1754
See also:
More about Alymsys (bevacizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Alymsys drug information
- Alymsys (Bevacizumab Intravenous) (Advanced Reading)
- Alymsys (Bevacizumab-maly Intravenous) (Advanced Reading)
Other brands
Avastin, Mvasi, Zirabev, Vegzelma, Avzivi
Professional resources
Other brands
Avastin, Mvasi, Zirabev, Vegzelma, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.